Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Rakovina Therapeutics Inc V.RKV

Alternate Symbol(s):  RKVTF

Rakovina Therapeutics Inc. is a Canada-based biopharmaceutical company. The Company is engaged in advancing cancer therapies based on deoxyribonucleic acid (DNA)-damage response technologies. The Company has a pipeline of DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials and obtain marketing approval for cancer therapeutics. The Company’s research... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:RKV)

Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today

GlobeNewswire April 9, 2024

Rakovina Therapeutics To Host Informational Webinar on April 3, 2024

GlobeNewswire April 1, 2024

Rakovina Therapeutics Announces Strategic Pivot to AI

GlobeNewswire March 27, 2024

Rakovina Therapeutics Inc. Announces Q3 2023 Financial Results and Provides Corporate Update

GlobeNewswire November 27, 2023

Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company's Scientific Advisory Board

GlobeNewswire November 27, 2023

Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member

GlobeNewswire November 20, 2023

Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update

GlobeNewswire August 29, 2023

Rakovina Therapeutics Announces Results from 2023 Annual General Meeting

GlobeNewswire June 28, 2023

Rakovina Therapeutics Inc. Announces Q1 2023 Financial Results and Provides Corporate Update

GlobeNewswire May 31, 2023
View More News ››

Opinion & Analysis (TSXV:RKV)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:RKV)

RKV at an offline event

How surprsing is that? I think it is solid info that RKV gonna attend an offline event https://ow.ly/b6wJ50PG2Qh. Its about time we...
sharonw - August 30, 2023

RE:2021 Financial Results/Provides Corporate Update TSXV:RKV

https://www.rakovinatherapeutics.com/
anjz661 - June 15, 2022

2021 Financial Results/Provides Corporate Update TSXV:RKV

VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a...
Betteryear2 - April 27, 2022

Rakovina Therapeutics Presents Preclinical Data Supporting

VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a...
Betteryear2 - April 12, 2022

InvestmentPitch Media Video

Vancouver, British Columbia--(Newsfile Corp. - November 17, 2021) - Rakovina Therapeutics Inc. (TSXV: RKV), a biopharmaceutical company...
Betteryear2 - November 17, 2021

The Power Play by The Market Herald Releases New Interviews

Rakovina (RKV) is partnering with St. Baldrick's Foundation to develop treatments for childhood bone cancer. It was selected to...
Betteryear2 - November 16, 2021
View more Bullboard ››

Enerev5 Metals Inc

Enerev5 Metals Inc

Enerev5 Metals Inc. is a Canadian resource company. The Company is focused on the exploration and development potential ...
View More »